Format
Sort by

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 79

1.

Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis.

Brown DC, Boston RC, Coyne JC, Farrar JT.

J Am Vet Med Assoc. 2008 Oct 15;233(8):1278-83.

2.

Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.

Sugimoto K, Rashid IB, Kojima K, Shoji M, Tanabe J, Tamasawa N, Suda T, Yasujima M.

Diabetes Metab Res Rev. 2008 Nov-Dec;24(8):642-50. doi: 10.1002/dmrr.903.

PMID:
18973207
3.

Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards.

Rice AS, Cimino-Brown D, Eisenach JC, Kontinen VK, Lacroix-Fralish ML, Machin I; Preclinical Pain Consortium., Mogil JS, Stöhr T.

Pain. 2008 Oct 15;139(2):243-7. doi: 10.1016/j.pain.2008.08.017. Review. No abstract available.

PMID:
18814968
4.

Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.

Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L.

BMC Neurol. 2008 Sep 16;8:33. doi: 10.1186/1471-2377-8-33.

5.

Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans.

Whiteside GT, Adedoyin A, Leventhal L.

Neuropharmacology. 2008 Apr;54(5):767-75. doi: 10.1016/j.neuropharm.2008.01.001. Review.

PMID:
18289614
6.

Development of a canine nociceptive thermal escape model.

Wegner K, Horais KA, Tozier NA, Rathbun ML, Shtaerman Y, Yaksh TL.

J Neurosci Methods. 2008 Feb 15;168(1):88-97.

7.

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.

Salvatore CA, Hershey JC, Corcoran HA, Fay JF, Johnston VK, Moore EL, Mosser SD, Burgey CS, Paone DV, Shaw AW, Graham SL, Vacca JP, Williams TM, Koblan KS, Kane SA.

J Pharmacol Exp Ther. 2008 Feb;324(2):416-21.

8.

The neuropathic pain triad: neurons, immune cells and glia.

Scholz J, Woolf CJ.

Nat Neurosci. 2007 Nov;10(11):1361-8. Review.

PMID:
17965656
9.

High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition.

Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR.

Diabetes. 2007 Oct;56(10):2598-608.

10.

Nociceptor sensitization to mechanical and thermal stimuli in pig skin in vivo.

Rukwied R, Dusch M, Schley M, Forsch E, Schmelz M.

Eur J Pain. 2008 Feb;12(2):242-50.

PMID:
17611131
11.

Kinetic gait and subjective analysis of the effects of a tachykinin receptor antagonist in dogs with sodium urate-induced synovitis.

Punke JP, Speas AL, Reynolds LR, Claxton RF, Budsberg SC.

Am J Vet Res. 2007 Jul;68(7):704-8.

PMID:
17605604
12.
13.

Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.

Vareniuk I, Pavlov IA, Drel VR, Lyzogubov VV, Ilnytska O, Bell SR, Tibrewala J, Groves JT, Obrosova IG.

Exp Neurol. 2007 Jun;205(2):425-36.

PMID:
17475250
14.

Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.

Hawkinson JE, Szoke BG, Garofalo AW, Hom DS, Zhang H, Dreyer M, Fukuda JY, Chen L, Samant B, Simmonds S, Zeitz KP, Wadsworth A, Liao A, Chavez RA, Zmolek W, Ruslim L, Bova MP, Holcomb R, Butelman ER, Ko MC, Malmberg AB.

J Pharmacol Exp Ther. 2007 Aug;322(2):619-30.

15.

Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.

Drag M, Kunkle BN, Romano D, Hanson PD.

Vet Ther. 2007 Spring;8(1):41-50.

PMID:
17447224
16.

Differential hypertrophy and atrophy among all types of cutaneous innervation in the glabrous skin of the monkey hand during aging and naturally occurring type 2 diabetes.

Paré M, Albrecht PJ, Noto CJ, Bodkin NL, Pittenger GL, Schreyer DJ, Tigno XT, Hansen BC, Rice FL.

J Comp Neurol. 2007 Apr 1;501(4):543-67.

PMID:
17278131
17.

Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the rat.

Bishop T, Hewson DW, Yip PK, Fahey MS, Dawbarn D, Young AR, McMahon SB.

Pain. 2007 Sep;131(1-2):70-82.

PMID:
17257754
18.
19.

Comparison of antinociceptive actions of standard analgesics in attenuating capsaicin and nerve-injury-induced mechanical hypersensitivity.

Joshi SK, Hernandez G, Mikusa JP, Zhu CZ, Zhong C, Salyers A, Wismer CT, Chandran P, Decker MW, Honore P.

Neuroscience. 2006 Dec 1;143(2):587-96.

PMID:
16962719
20.

Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.

Ryan WG, Moldave K, Carithers D.

Vet Ther. 2006 Summer;7(2):119-26.

PMID:
16871494
Items per page

Supplemental Content

Support Center